Sylogent Launches Pharma Approvals Module
Sylogent Launches Approvals Module to Give Pharma Executives Single Tool for All Approvals
(firmenpresse) - NEWTOWN, PA -- (Marketwire) -- 11/10/11 -- Sylogent today announced that it completed development on its Approvals Module and the company expects to deploy the system for several clients by year's end.
"Biopharma and device company SOPs typically require an extensive approval process before clinical data, documents or other materials can be disclosed," stated Jack Yeager, CEO of Sylogent. "In talking with our industry contacts, we understand that the approval process typically is managed by using a home-grown system, an offline committee, or requires executive approvers to learn multiple systems to manage a piecemeal approvals process."
"We have identified an increasing demand for a single, simple, disclosure approvals system," stated Yeager. "Sylogent has extensive experience in managing approvals processes that we gained through our PubSTRAT, VCTR, ReCAP, and Publish II solutions currently active in a wide range of customers."
With the Approvals Module Sylogent envisions a configurable solution that will centralize and streamline the enterprise approvals processes in research, clinical development and publication planning. The Approvals Module will offer direct entry for new approval requests, but also can receive requests routed from third-party applications.
The Approvals Module represents the first module in Sylogent's new SylogIQ Platform that aims to organize, standardize and automate the clinical development process for our customers. "Our goal is to drive compliance, maximize efficiencies and dramatically reduce operating costs. We aim to save our customers millions of dollars," said Yeager.
"As we work with our customers' data, we've become aware of a growing need for standardized data and metadata in clinical development systems, to reduce re-keying or data migration workloads as data are moved from protocol to trial registration to results reporting to publications, with all the many steps in between," stated Yeager.
About Sylogent
Sylogent provides software and business support services to the pharmaceutical industry. The company focuses on simplifying the clinical development process by deploying tools that are critical to operations and that save clients both time and millions of dollars of unnecessary costs.
For more information, please e-mail
Sylogent
215.504.7000 x 1
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 10.11.2011 - 16:21 Uhr
Sprache: Deutsch
News-ID 86586
Anzahl Zeichen: 0
contact information:
Town:
NEWTOWN, PA
Kategorie:
Medical Devices
Diese Pressemitteilung wurde bisher 423 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Sylogent Launches Pharma Approvals Module"
steht unter der journalistisch-redaktionellen Verantwortung von
Sylogent (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
